The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction ...

Producing large quantities of designer DNA nanostructures at low cost has ... Using phages and bacteria such as Escherichia coli to make many identical copies of, or 'clone', a gene represents ...

Restriction enzymes are one of the most important tools in the recombinant DNA technology ... which the enzyme has been isolated (e.g., Eco- for E. coli and Hin- for H. influenzae), and the ...

WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA (pDNA). The worldwide market for microbial-derived ...

The modified genomes are then transferred to E. coli, which makes isolating them ... modifications introduced in the synthetic DNA. These recombinant viruses can then be used for further study ...

E. coli, a foodborne bacteria that infects around 75,000-90,000 Americans each year and at least 1,500 Britons. By analyzing DNA from young colon cancer patients, the team found unique genetic ...

Vienna, Austria – May 9th 2025 – Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its ...

Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at Biomay's headquarters manufacturing site in Vienna, Seestadt in December 2024.

The "Ligase Market - A Global and Regional Analysis: Focus on Product, Source, Application, End User, and Country - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...